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ABSTRACT
Objective Minimally invasive surgical necrosectomy 
and endoscopic necrosectomy, compared with open 
necrosectomy, might improve outcomes in necrotising 
pancreatitis, especially in critically ill patients. evidence from 
large comparative studies is lacking.
Design We combined original and newly collected data 
from 15 published and unpublished patient cohorts (51 
hospitals; 8 countries) on pancreatic necrosectomy for 
necrotising pancreatitis. Death rates were compared in 
patients undergoing open necrosectomy versus minimally 
invasive surgical or endoscopic necrosectomy. to adjust for 
confounding and to study effect modification by clinical 
severity, we performed two types of analyses: logistic 
multivariable regression and propensity score matching 
with stratification according to predicted risk of death at 
baseline (low: <5%; intermediate: ≥5% to <15%; high: 
≥15% to <35%; and very high: ≥35%).
Results among 1980 patients with necrotising pancreatitis, 
1167 underwent open necrosectomy and 813 underwent 
minimally invasive surgical (n=467) or endoscopic (n=346) 
necrosectomy. there was a lower risk of death for minimally 
invasive surgical necrosectomy (Or, 0.53; 95% ci 0.34 to 
0.84; p=0.006) and endoscopic necrosectomy (Or, 0.20; 
95% ci 0.06 to 0.63; p=0.006). after propensity score 
matching with risk stratification, minimally invasive surgical 
necrosectomy remained associated with a lower risk of 
death than open necrosectomy in the very high-risk group 
(42/111 vs 59/111; risk ratio, 0.70; 95% ci 0.52 to 0.95; 
p=0.02). endoscopic necrosectomy was associated with a 
lower risk of death than open necrosectomy in the high-risk 
group (3/40 vs 12/40; risk ratio, 0.27; 95% ci 0.08 to 0.88; 
p=0.03) and in the very high-risk group (12/57 vs 28/57; 
risk ratio, 0.43; 95% ci 0.24 to 0.77; p=0.005).
Conclusion in high-risk patients with necrotising 
pancreatitis, minimally invasive surgical and endoscopic 
necrosectomy are associated with reduced death rates 
compared with open necrosectomy.
InTRODuCTIOn
Approximately 20% of patients with acute pancre-
atitis develop necrosis of the pancreas and peri-
pancreatic tissue.1 These patients have a prolonged 
disease course with a high risk of complications 
such as multiple organ failure, secondary infection 
of the necrosis and death.1 2 Many patients with 
necrotising pancreatitis ultimately need to undergo 
pancreatic necrosectomy.1–4
Death rates after pancreatic necrosectomy 
recently reported by international specialist centres 
vary from 0% to 25%.5–12 This variation may be 
explained by differences in case-mix or by differ-
ences in treatment strategies and local expertise. 
Several changes in the treatment of patients with 
necrotising pancreatitis have occurred over the last 
20 years. First, the timing of intervention has shifted 
from very early in the disease course to around 
3–4 weeks after onset of symptoms.3 4 13 Second, 
the indication for necrosectomy has changed 
from sterile necrosis to predominantly infected 
necrosis.3 4 14 Third, percutaneous or endoscopic 
drainage of the necrotic collection is now often 
the first step in treatment before necrosectomy.15 
Finally, as an alternative to open necrosectomy, 
minimally invasive surgical necrosectomy and the 
even less invasive endoscopic necrosectomy are 
increasingly being performed.7–10 12
Minimally invasive necrosectomy is thought to 
be beneficial in the acute phase by inducing less 
surgical stress, thereby lowering the proinflam-
matory response, especially in already critically ill 
patients.16 17 Another advantage is the avoidance 
of the long-term morbidity of a large abdominal 
incision. Studies that directly compare minimally 
invasive necrosectomy with open necrosectomy 
for primary clinical outcomes are scarce. A few 
retrospective studies have been performed, but 
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these were mostly small and hampered by selection bias and 
confounding.12 18 The only available randomised trial included 
only 20 patients.17 Despite the lack of evidence in favour of 
minimally invasive surgical and endoscopic necrosectomy, these 
techniques are increasingly popular in the treatment of necro-
tising pancreatitis. This, combined with the fact that necrotising 
pancreatitis is a complex and relatively rare disease, makes it 
unlikely that a trial with a sufficiently large sample size to study 
mortality will ever be performed. It therefore remains unclear if 
minimally invasive necrosectomy methods reduce death rates, 
especially in the context of other recent changes in the treat-
ment of necrotising pancreatitis. As a result, open necrosectomy 
remains a valid option and is still practised worldwide.3 11 19 20
In this international collaborative project, we combined orig-
inal patient data from published and unpublished cohorts on 
pancreatic necrosectomy in specialist centres worldwide. We 
compared death rates of open necrosectomy with minimally 
invasive surgical and endoscopic necrosectomy in a large number 
of patients. This allowed for several approaches to adjust for 
confounding and to study effect modification by clinical severity. 
We hypothesised that minimally invasive necrosectomy reduced 
death rates.
METhODS
Study design
We combined original study data from patients undergoing 
pancreatic necrosectomy in 51 hospitals who were included in 15 
cohorts from specialist pancreatic centres in the USA and Canada 
(n=4), UK (n=4), Germany (n=2), Hungary (n=2), The Neth-
erlands (n=1), India (n=1) and Brazil (n=1). The cohorts were 
identified by a predefined systematic literature search. A total 
of 13 cohorts were published previously.6–10 19 21–27 For four of 
these cohorts,7 10 19 24 additional patients were included of whom 
the data were unpublished and two cohorts consist of entirely 
unpublished data. Details on the search, eligibility criteria, 
included cohorts and quality assessment/risk of bias of individual 
studies are available in the online supplementary appendix 
(p4–5). Once the corresponding author of a cohort agreed to 
participate, case record forms containing original and additional 
individual patient data regarding baseline characteristics, method 
of intervention and clinical outcomes were collected. All data 
were anonymised. The institutional review boards of the partic-
ipating centres approved study protocols, if appropriate. The 
study design was predefined and prospectively registered (www. 
crd. york. ac. uk/ PROSPERO: CRD42014008995). We adhered 
to the STROBE guidelines (The Strengthening the Reporting of 
Observational Studies in Epidemiology) and the PRISMA-IPD 
guidelines (Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses for Individual Patient Data).28 29
Data collection
Data were collected in a standardised manner using an elec-
tronic case record form. The following baseline variables were 
collected: sex, age, tertiary referral, cause of pancreatitis, cath-
eter drainage before necrosectomy, time from hospital admission 
to necrosectomy, Acute Physiology and Chronic Health Evalua-
tion II (APACHE-II) score and organ failure ≤24 hours before 
necrosectomy, documented infection of necrosis, and year of 
necrosectomy. Method of necrosectomy (ie, open necrosec-
tomy, minimally invasive surgical necrosectomy or endoscopic 
necrosectomy), complications and death were also recorded. 
Further details on data collection and definitions of variables are 
provided in the online supplementary appendix (p5–6).
Data were checked for consistency and plausibility. Data were 
missing in 8 of the 13 baseline variables, with a range of 0.2%–
4.7%. Missing data were imputed by multiple imputation using 
chained equations. More information on missing data and impu-
tation is available in the online supplementary appendix (p6–7).
Statistical analysis
Patients undergoing open necrosectomy were compared with 
patients undergoing minimally invasive surgical necrosectomy 
and with patients undergoing endoscopic necrosectomy. The 
Significance of this study
What is already known on this subject?
 ► In patients with infected necrotising pancreatitis, endoscopic 
or percutaneous catheter drainage of the necrotic collection 
as a first step is now considered standard treatment.
 ► Patients in whom drainage alone does not lead to clinical 
recovery need to undergo a more invasive necrosectomy 
procedure.
 ► Minimally invasive surgical necrosectomy and endoscopic 
necrosectomy are gaining popularity over open 
necrosectomy. There is, however, no clear evidence from 
large comparative studies with clinical endpoints in 
favour of minimally invasive techniques. As a result, open 
necrosectomy is still an option in treatment guidelines, and 
observational studies on open necrosectomy continue to be 
published.
 ► A randomised trial comparing minimally invasive surgical 
or endoscopic necrosectomy with open necrosectomy 
with death as primary endpoint will most likely never be 
performed.
What are the new findings?
 ► This study included 1980 patients who underwent 
necrosectomy for acute necrotising pancreatitis in 51 
hospitals across 8 countries worldwide.
 ► Detailed individual patient data were collected, and patients 
undergoing minimally invasive necrosectomy were compared 
with patients undergoing open necrosectomy for the primary 
endpoint of in-hospital death.
 ► To adjust for potential confounding and to study effect 
modification by clinical severity, thorough statistical 
analyses included multivariable regression modelling and 
propensity score matching with stratification according to 
prenecrosectomy risk of death.
 ► Minimally invasive surgical and endoscopic necrosectomy 
were associated with lower death rates than open 
necrosectomy in patients who were severely ill at time of 
necrosectomy.
how might it impact on clinical practice in the foreseeable 
future?
 ► This study combined individual patient data from leading 
pancreatic specialist centres worldwide to form the 
largest known cohort of patients undergoing pancreatic 
necrosectomy. Even after adjusting for potential confounding 
by several methods, minimally invasive necrosectomy 
reduced mortality in the most severely ill patients. These 
findings suggest that treatment guidelines should discourage 
the open approach as initial treatment in patients with 
infected necrotising pancreatitis in need of necrosectomy.
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primary endpoint was in-hospital death during index admis-
sion. Readmissions within 10 days after discharge from index 
admission were considered as part of the index admission. 
Patients were analysed according to the intention-to-treat 
principle. We anticipated that certain prognostic baseline 
variables that are associated with death, such as measures of 
disease severity, would not be evenly distributed among treat-
ment groups. This could be due to selection bias in the indi-
vidual cohorts or because clinical severity played a role in 
deciding which method of necrosectomy was performed (ie, 
confounding by indication or confounding by severity).30 To 
adjust for confounding and to explore effect modification by 
clinical severity, we performed two main analyses.
The first main analysis was a multivariable logistic regression 
analysis to evaluate the association between different methods 
of necrosectomy and death. Formation of a directed acyclic 
graph was used to aid selection of covariates to be included in 
the model (see online supplementary appendix (p7,13)).31 The 
following factors were included as covariates: age, documented 
infected necrosis, study cohort, time since hospital admission, 
year of necrosectomy and severity of disease parameters within 
24 hours of necrosectomy, and APACHE-II score, cardiovascular 
failure, pulmonary failure and renal failure. To study the effect 
of disease severity as a modifier on the outcome, we performed 
a secondary analysis in which an interaction term for severity 
with method of necrosectomy was added to the final multivari-
able model. We chose the APACHE-II score at time of necro-
sectomy (ie, APACHE <7, ≥7 to <11, ≥11 to <15, and ≥15) 
as the disease severity indicator in these analyses because it is 
a composite of clinical and laboratory parameters indicative of 
disease severity at a specific point in time.32
The second main analysis was a propensity score-matched 
analysis with risk stratification. Recognising severity of disease 
as a possible effect modifier (ie, the beneficial effect of minimally 
invasive necrosectomy is greater in more severely ill patients), all 
patients were stratified according to their predicted risk of death 
at baseline. To accomplish this, a prediction model for the risk of 
death determined at baseline (ie, within 24 hours before necro-
sectomy) was developed using the data from patients undergoing 
open necrosectomy (ie, the control group).33 First, the univari-
able association was determined between death and all of the 
following baseline characteristics: study cohort, sex, age, year 
of necrosectomy, cause of pancreatitis, tertiary referral, catheter 
drainage before necrosectomy, documented infected necrosis, 
time since hospital admission and severity of disease parameters 
within 24 hours of necrosectomy, APACHE-II score, cardiovas-
cular failure, pulmonary failure and renal failure. All factors with 
p<0.1 were included in a multivariable regression analysis, with 
forced entry of sex and infected necrosis (ie, a variable hypoth-
esised to have major prognostic value). Variables were excluded 
using stepwise backward elimination (p>0.05). Variables that 
remained independently associated with death in the multivari-
able model were study cohort, age, APACHE-II score, cardiovas-
cular failure, pulmonary failure and renal failure. Performance 
of the model was very good with an area under the curve of 
0.85. We chose this method as opposed to classifying severity of 
pancreatitis in general by the recently revised Atlanta classifica-
tion1 or the determinant-based classification of acute pancreatitis 
severity34 because we specifically wanted to determine disease 
severity at the time of necrosectomy.
Using this model, patients in each treatment group were 
assigned to one of four baseline categories of predicted risk 
of death: low (<5%); intermediate (≥5% to <15%); high 
(≥15% to <35%); or very high (≥35%). Further details on 
the prediction model and risk stratification are available in 
the online supplementary appendix (p7). Within the four risk 
groups, patients were matched using their propensity score to 
create cohorts of patients with similar baseline characteristics. 
The propensity score is the probability of treatment assignment 
conditional on observed baseline characteristics and allows one 
to design and analyse an observational study so that it mimics 
some of the characteristics of a randomised trial.35 We devel-
oped a non-parsimonious multivariable logistic regression model 
to estimate a propensity score for minimally invasive surgical 
necrosectomy and endoscopic necrosectomy. This included study 
cohort as a cofactor to adjust for potential hidden confounders 
(eg, better supportive intensive care in more recent years). 
Details of the individual variables included in the model are 
provided in the online supplementary appendix (p8). Patients 
undergoing minimally invasive surgical necrosectomy or endo-
scopic necrosectomy were matched 1:1 with patients under-
going open necrosectomy using their propensity score with the 
nearest neighbour matching algorithm without replacement (a 
calliper width equal to 0.2 of the SD of the logit score was used). 
Standardised differences were estimated for all the baseline 
covariates to assess imbalance before matching and balance after 
matching. A standardised difference of less than 10% indicates 
appropriate balance.35
Results of multivariable regression analysis are given as 
ORs and 95% CIs. Differences in death rates were tested with 
the McNemar’s test for paired data in the matched cohorts. 
Comparisons of death rates are presented as risk ratios. All tests 
were two-tailed and p values of less than 0.05 were considered 
statistically significant.
Predefined subgroup analyses were performed for patients with 
infected necrosis and for patients who underwent previous cath-
eter drainage. Several other sensitivity analyses were performed 
in the comparison of minimally invasive necrosectomy and open 
necrosectomy (see online supplementary appendix (p8)). We 
also compared endoscopic necrosectomy with minimally inva-
sive surgical necrosectomy on the primary outcome death using 
propensity score matching and risk stratification.
RESulTS
Study population
We included 1980 patients who underwent pancreatic necrosec-
tomy; a total of 1167 patients underwent open necrosectomy, 
467 patients underwent minimally invasive surgical necrosec-
tomy and 346 patients underwent endoscopic necrosectomy. 
Baseline characteristics for the entire study population and 
per study cohort are presented in the online supplementary 
appendix (p21–23). A total of 325 out of 1980 patients (16%) in 
the study died during index admission.
logistic regression adjusted analysis
While adjusting for confounders (ie. cohort, age, documented 
infected necrosis, study cohort, time since hospital admission, 
year of necrosectomy and severity of disease parameters within 
24 hours of necrosectomy, APACHE-II score, cardiovascular 
failure, pulmonary failure and renal failure), method of necrosec-
tomy was significantly associated with death (see online supple-
mentary appendix (p24). Compared with open necrosectomy, 
minimally invasive surgical necrosectomy displayed an OR of 
0.53 (95% CI 0.34 to 0.84; p=0.006), and endoscopic necrosec-
tomy an OR of 0.20 (95% CI 0.06 to 0.63; p=0.006).
Inclusion of the interaction term ‘disease severity (APACHE-II 
score) by method of necrosectomy’ showed that endoscopic 
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necrosectomy was associated with less mortality irrespective of 
the APACHE-II score (OR 0.13; 95% CI 0.02 to 0.95; p=0.04). 
The interaction term ‘APACHE-II score by minimally invasive 
surgical necrosectomy’ confirmed that clinical severity is an 
effect modifier, as minimally invasive surgical necrosectomy 
only remained associated with less mortality in patients with 
the highest APACHE-II scores (OR 0.27; 95% CI 0.08 to 0.88; 
p=0.03). Detailed results of this secondary regression analyses 
are provided in the online supplementary appendix (p25).
Propensity score-matched analysis with risk stratification
Using a multivariable prediction model (see online supplemen-
tary appendix (p26)), patients were stratified according to their 
predicted risk of death at baseline. Stratification was considered 
successful because there were no major differences in predicted 
risk of death for patients undergoing open necrosectomy, mini-
mally invasive surgical necrosectomy and endoscopic necrosec-
tomy, respectively: low-risk group: median 2% (IQR, 1%–3%) 
vs median 3% (IQR, 0%–4%) vs median 4% (IQR, 2%–4%); 
intermediate-risk group: median 9% (IQR, 7%–11%) vs median 
9% (IQR, 7%–12%) vs median 10% (IQR, 8%–12%); high-risk 
group: median 24% (IQR, 18%–29%) vs median 22% (IQR, 
19%–29%) vs median 22% (IQR, 19%–27%); and very high-
risk group: median 52% (IQR, 43%–64%) vs median 58% 
(IQR, 45%–78%) vs 51% (IQR, 42%–72%).
Subsequently, a total of 376 patients who underwent mini-
mally invasive surgical necrosectomy were matched with 376 
patients who underwent open necrosectomy, and a total of 
198 patients who underwent endoscopic necrosectomy were 
matched with 198 patients who underwent open necrosec-
tomy. Baseline characteristics in each risk group for unmatched 
and matched cohorts are presented in tables 1 and 2. In the 
unmatched cohorts, although predicted risk of death was 
similar within each of the four risk groups, significant imbalance 
in individual baseline characteristics remained after risk strati-
fication, as indicated by standardised mean differences greater 
than 10%. The matched cohorts were well balanced for all 
baseline characteristics because none of the standardised differ-
ences exceeded 10%. There was sufficient overlap in propensity 
scores as is shown in the online supplementary appendix figures 
4 and 5.
Actual death rates in the matched cohorts in each risk group 
are shown in figure 1. Minimally invasive surgical necrosectomy 
was associated with a lower risk of death than open necrosec-
tomy in the very high-risk group (risk ratio 0.70; 95% CI 0.52 
to 0.95; p=0.02). Endoscopic necrosectomy was associated 
with a lower risk of death than open necrosectomy in the high-
risk group (risk ratio 0.27; 95% CI 0.08 to 0.88; p=0.03) and 
the very high-risk group (risk ratio 0.43; 95% CI 0.24 to 0.77; 
p=0.005), with judgement suspended in the intermediate-risk 
group (risk ratio 0.14; 95% CI 0.02 to 1.10; p=0.06).
Subgroup and sensitivity analyses
The propensity score-matched analysis was also performed in 
the subgroups of patients with documented infected necrosis 
(403 patients (86%) in the minimally invasive surgical group, 
197 patients (57%) in the endoscopic group and 885 patients 
(76%) in the open necrosectomy group) and in patients who 
underwent previous catheter drainage (436 patients (93%) in 
the minimally invasive surgical group, 178 patients (51%) in the 
endoscopic group and 210 patients (18%) in the open necro-
sectomy group). Baseline characteristics for the unmatched and 
the matched cohorts and the actual death rates after matching 
are provided in the online supplementary appendix (p27–42). 
Results were in line with the primary analyses.
Exclusion of patients undergoing necrosectomy before 3 weeks 
(ie, <22 days) after admission from the matched cohorts resulted 
in loss of nearly half of all pairs in each of the two compared 
groups. Patients undergoing minimally invasive necrosectomy 
still had lower death rates, although statistical significance was 
no longer reached (see online supplementary appendix p59).
As alternative risk stratification, patients were stratified 
according to their APACHE-II score within 24 hours before 
necrosectomy (ie, <7, ≥7 to <11, ≥11 to <15, and ≥15) 
and matched with propensity score matching (online supple-
mentary appendix (p43–48)). Similar to the primary analyses, 
minimally invasive surgical necrosectomy and endoscopic 
necrosectomy were associated with a lower actual death rate 
in the higher APACHE-II groups (see online supplementary 
appendix (p49–50)).
In addition to death, other study outcomes included postoper-
ative complications (ie, bleeding and pancreatic fistula), number 
of necrosectomies and hospital stay after necrosectomy. In the 
matched cohorts, bleeding occurred in 5%–19% of patients and 
was more frequent in the higher risk of death groups. There 
was no statistically significant difference for the complication 
bleeding between minimally invasive necrosectomy methods and 
open necrosectomy. Pancreatic fistula occurred in 4%–35% of 
patients, was more frequent in patients at lower risk of death 
and occurred more often in patients who underwent open necro-
sectomy. Overall, patients who underwent minimally invasive 
surgical necrosectomy had the longest hospital stay after necro-
sectomy (median over the four risk groups ranging from 32 to 
59 days), followed by open necrosectomy (median ranging from 
21 to 52 days) and endoscopic necrosectomy (median ranging 
from 5 to 42 days). The number of necrosectomies was highest 
in the endoscopic groups (median ranging from 3 to 4), followed 
by the minimally invasive surgical groups (median ranging from 
2 to 3) and open necrosectomy groups (median 1). Detailed 
results with respect to all other outcomes in each risk group are 
provided in the online supplementary appendix (p51–54).
In our secondary comparison of endoscopic necrosectomy 
with minimally invasive surgical necrosectomy, 215 patient 
pairs were matched. Baseline characteristics before and after 
matching in each risk group are presented in the online supple-
mentary appendix (p55–57). In the matched cohorts, the 
differences in death rates between the endoscopic groups and 
minimally invasive surgical groups were not statistically signifi-
cant (see online supplementary appendix (p58)).
DISCuSSIOn
In this international collaborative study involving 1980 patients 
with necrotising pancreatitis from 51 hospitals across 8 coun-
tries, minimally invasive surgical necrosectomy or endoscopic 
necrosectomy compared with open necrosectomy significantly 
decreased mortality among high-risk patients. In contrast to 
meta-analyses which pool data directly from published results 
(ie, paper analysis), this study provides a combined analysis of 
original, individual patient data of previously published cohorts 
(including unpublished data from ongoing registries) and unpub-
lished cohorts.
A large number of, mostly retrospective, cohort studies have 
reported outcomes of patients undergoing minimally invasive 
pancreatic necrosectomy. Few studies, however, have directly 
compared minimally invasive necrosectomy with open necrosec-
tomy. One meta-analysis, based on paper analysis of four studies, 
group.bmj.com on April 12, 2018 - Published by http://gut.bmj.com/Downloaded from 
701van Brunschot S, et al. Gut 2018;67:697–706. doi:10.1136/gutjnl-2016-313341
Endoscopy
Table 1 Baseline characteristics before and after propensity score matching of patients undergoing minimally invasive surgical necrosectomy or 
open necrosectomy*
Characteristics Before matching After matching
Minimally 
invasive surgical 
necrosectomy 
(n=97)
Open 
necrosectomy 
(n=377)
Standardised 
difference (%)
Minimally 
invasive surgical 
necrosectomy 
(n=87)
Open 
necrosectomy 
(n=87)
Standardised 
difference (%)
Low risk of death (<5%)
  Male sex, n (%) 65 (68) 276 (73) 12.7 63 (72) 61 (70) 4.1
  Age 43±12 44±13 9.5 44±12 45±14 5.7
  Cause, n (%)
   Gallstones 50 (51) 111 (29) 46.2 40 (46) 38 (44) 5.5
   Alcohol 28 (29) 177 (47) 38.0 28 (32) 27 (31) 1.5
   Other 19 (20) 89 (24) 9.7 19 (22) 22 (25) 8.0
  APACHE-II score† 6.0±3.4 7.7±4.2 47.0 6.3±3.4 6.0±3.7 6.3
  Cardiovascular failure, n (%)†‡ 0 (0) 7 (2) 19.7 0 (0) 0 (0) 0
  Pulmonary failure, n (%)†§ 3 (3) 30 (8) 21.2 3 (3) 3 (3) 0.5
  Renal failure, n (%)†¶ 2 (2) 10 (3) 4.2 2 (2) 2 (2) 3.9
  Documented infected necrosis, n (%)** 88 (91) 279 (74) 47.0 79 (90) 79 (90) 0.6
  Tertiary referral, n (%) 77 (80) 205 (55) 56.3 68 (78) 68 (78) 1.2
  Time since hospital admission,  
days
56±53 51±133 5.2 56±54 66±158 7.6
Minimally 
invasive surgical 
necrosectomy
(n=119)
Open 
necrosectomy
(n=343)
Standardised 
difference (%)
Minimally 
invasive surgical 
necrosectomy
(n=108)
Open 
necrosectomy
(n=108)
Standardised 
difference (%)
Intermediate risk of death (≥5% to <15%)
  Male sex, n (%) 82 (69) 229 (67) 5.1 74 (69) 73 (68) 2.0
  Age 54±15 53±14 5.9 54±14 55±13 6.2
  Cause, n (%)
   Gallstones 65 (55) 139 (40) 29.2 56 (52) 53 (49) 5.3
   Alcohol 29 (24) 119 (35) 23.0 28 (26) 30 (28) 3.3
   Other 25 (21) 85 (25) 9.6 24 (22) 25 (23) 2.6
  APACHE-II score† 7.9±3.0 10.0±4.1 57.9 8.2±2.8 8.1±3.5 4.6
  Cardiovascular failure, n (%)†‡ 3 (3) 65 (19) 53.2 3 (3) 3 (3) 5.8
  Pulmonary failure, n (%)†§ 8 (7) 113 (33) 68.1 8 (8) 6 (6) 8.4
  Renal failure, n (%)†¶ 5 (4) 42 (12) 29.7 5 (5) 4 (4) 6.0
  Documented infected necrosis, n (%)** 95 (80) 270 (79) 3.2 87 (81) 88 (82) 2.0
  Tertiary referral, n (%) 95 (80) 208 (61) 43.3 84 (78) 82 (76) 4.3
  Time since hospital admission,  
days
48±41 30±27 50.0 43±33 41±36 5.1
Minimally 
invasive surgical 
necrosectomy
(n=120)
Open 
necrosectomy
(n=225)
Standardised 
difference (%)
Minimally 
invasive surgical 
necrosectomy
(n=70)
Open 
necrosectomy
(n=70)
Standardised 
difference (%)
High risk of death (≥15% to <35%)
  Male sex, n (%) 65 (54) 140 (62) 17.5 43 (61) 44 (63) 4.1
  Age 57±13 58±14 7.1 59±13 59±14 4.2
  Cause, n (%)
   Gallstones 72 (60) 88 (39) 43.0 35 (50) 36 (51) 1.7
   Alcohol 31 (25) 81 (36) 23.2 21 (30) 21 (30) 0.6
   Other 17 (15) 56 (25) 26.3 14 (20) 13 (19) 3.0
  APACHE-II score† 10.1±4.3 12.8±4.2 62.2 11.3±3.9 11.2±3.5 0.9
  Cardiovascular failure, n (%)†‡ 25 (21) 98 (44) 51.2 20 (29) 22 (31) 4.3
  Pulmonary failure, n (%)†§ 25 (21) 145 (65) 97.6 23 (32) 24 (34) 4.8
  Renal failure, n (%)†¶ 7 (6) 65 (29) 64.7 7 (10) 7 (10) 2.8
  Documented infected necrosis, n (%)** 97 (81) 182 (81) 0.5 60 (85) 61 (87) 3.3
  Tertiary referral, n (%) 99 (83) 160 (71) 27.4 58 (83) 58 (83) 0.4
  Time since hospital admission,  
days
35±22 24±19 56.4 29±14 29±22 1.6
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compared 215 patients undergoing minimally invasive surgical 
necrosectomy with 121 patients undergoing open necrosec-
tomy.18 Mortality was 17% after minimally invasive surgical 
necrosectomy vs 30% after open necrosectomy (OR 0.43; 
95% CI 0.01 to 8.60; p=0.06). This meta-analysis, however, 
suffered from significant heterogeneity. Another single-centre 
study compared 274 patients undergoing minimally invasive 
surgical necrosectomy with 120 patients undergoing open necro-
sectomy; mortality was 15% vs 23% (p=0.06).12 Our study, 
with individual patient data, differed from these earlier studies 
because of its much larger sample size, and as a consequence the 
possibility to analyse different risk groups and to adjust for the 
effects of confounding and selection bias. Moreover, this study 
was novel in performing a head-to-head comparison of patients 
undergoing different methods of necrosectomy, in contrast 
to a previously published randomised study comparing open 
necrosectomy with a step-up approach (ie, catheter drainage 
followed, if necessary, by minimally invasive necrosectomy)15 
and a recently finished trial comparing an endoscopic step-up 
approach with a surgical step-up approach (ISRCTN09186711).
How can the lower death rates after minimally invasive necro-
sectomy be explained? It is well known that, in various diseases, 
minimally invasive surgical techniques induce less surgical stress 
and thereby lead to a lower systemic proinflammatory response 
compared with open surgery.36 37 This was also demonstrated 
in necrotising pancreatitis: in the only randomised trial that 
compared endoscopic necrosectomy with surgical necrosectomy 
(a total of 20 patients), endoscopic necrosectomy reduced the 
levels of the proinflammatory cytokine interleukin (IL)-6 during 
the 7 days after the procedure.17 The more pronounced proin-
flammatory response invoked by open necrosectomy may facili-
tate organ failure or worsen pre-existing organ failure, especially 
in patients who are already suffering from a severe inflammatory 
condition such as necrotising pancreatitis.15 This seems of partic-
ular importance because organ failure is the main determinant 
for mortality in patients with necrotising pancreatitis, especially 
in the presence of infected necrosis.38 The same trial that demon-
strated lower levels of IL-6 after endoscopic necrosectomy also 
showed lower rates of postprocedure multiple organ failure.17 A 
reduction in multiple organ failure with less surgical stress was 
also seen in another randomised trial that compared primary 
catheter drainage with open necrosectomy in 88 patients with 
necrotising pancreatitis.15 In contrast with these previous 
trials,15 17 we did not study the rate of organ failure as a surrogate 
outcome. Our study was designed to evaluate the most relevant 
clinical endpoint of mortality, with a sufficiently large number of 
patients, even in the subgroups of the most severely ill patients.
Our results suggest that patients with necrotising pancreatitis 
who are severely ill should undergo minimally invasive surgical 
or endoscopic necrosectomy instead of open necrosectomy, 
given the expertise in these minimally invasive techniques is 
available. If the expertise is absent and the patient is clinically 
unfit for transport to a tertiary referral centre, open necrosec-
tomy may still be acceptable. In the propensity score-matched 
analysis, we did not find significantly lower death rates in the 
low-risk and intermediate-risk groups. These patients, who 
are in a relatively stable clinical condition, seem capable of 
sustaining the larger surgical stress and proinflammatory hit 
induced by open necrosectomy. Another explanation may be 
that, due to their lower a priori risk of death, the subgroup 
of less severely ill patients was too small to detect a difference 
in death between methods of necrosectomy. This is supported 
by the wide 95% CIs observed in these groups (figure 1). 
One could therefore argue that open necrosectomy is still a 
reasonable treatment option in these patients. However, other 
reasons to prefer minimally invasive necrosectomy techniques 
Characteristics Before matching After matching
Minimally 
invasive surgical 
necrosectomy
(n=131)
Open 
necrosectomy
(n=222)
Standardised 
difference (%)
Minimally 
invasive surgical 
necrosectomy 
(n=111)
Open 
necrosectomy
(n=111)
Standardised 
difference (%)
Very high risk of death (≥35%)
 Male sex, n (%) 81 (62) 146 (66) 8.2 68 (62) 70 (63) 2.6
 Age 63±12 62±14 5.5 62±12 63±13 0.9
  Cause, n (%)
  Gallstones 74 (56) 99 (44) 23.7 62 (56) 66 (60) 7.3
  Alcohol 37 (29) 66 (30) 2.3 30 (27) 29 (26) 1.2
  Other 20 (15) 57 (26) 26.8 19 (17) 16 (14) 8.5
  APACHE-II score† 16.8±5.7 16.6±5.3 3.3 17.0±5.7 17.1±5.5 1.2
  Cardiovascular failure, n (%)†‡ 91 (69) 179 (81) 25.9 81 (74) 84 (76) 5.8
  Pulmonary failure, n (%)†§ 90 (69) 182 (82) 30.9 79 (72) 78 (70) 2.0
  Renal failure, n (%)†¶ 59 (45) 123 (55) 21.0 53 (48) 50 (45) 4.4
  Documented infected necrosis, n (%)** 123 (94) 154 (69) 67.3 103 (93) 105 (95) 7.5
  Tertiary referral, n (%) 115 (88) 168 (76) 31.4 95 (86) 92 (83) 5.4
  Time since hospital admission, days 30±15 22±18 50.3 30±15 28±19 8.9
*± Values are mean±SD. A value of less than 10.0% of the standardised difference indicates a negligible difference between groups. Patients are stratified in four risk groups 
based on predicted death at baseline, which was determined by a multivariable prediction model incorporating study cohort, APACHE-II score, cardiovascular failure, pulmonary 
failure and renal failure in the 24 hours before necrosectomy (details on prediction model in the online supplementary appendix p7).
†Within 24 hours before necrosectomy.
‡Circulatory systolic blood pressure <90 mm Hg, despite adequate fluid resuscitation or need for inotropic catecholamine support.
§PaO2 <60 mm Hg, despite FIO2 of 30% or need for mechanical ventilation.
¶Creatinine level >177 μmol/L after rehydration or need for haemofiltration or haemodialysis.
**Positive microbiological culture from fine-needle aspiration before necrosectomy or from first catheter drainage before necrosectomy or from primary necrosectomy.
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Table 2 Baseline characteristics before and after propensity score matching of patients undergoing endoscopic necrosectomy or open 
necrosectomy*
Characteristics Before matching After matching
Endoscopic 
necrosectomy 
(n=31)
Open 
necrosectomy 
(n=377)
Standardised 
difference (%)
Endoscopic 
necrosectomy 
(n=29)
Open 
necrosectomy 
(n=29)
Standardised 
difference (%)
Low risk of death (<5%)
  Male sex, n (%) 22 (71) 276 (73) 5.3 21 (72) 21 (72) 1.4
  Age 39±11 44±13 49.4 39±11 40±10 1.1
  Cause, n (%)
   Gallstones 10 (32) 111 (29) 6.3 8 (28) 8 (28) 0.3
   Alcohol 8 (26) 177 (47) 45.2 8 (28) 8 (28) 0.3
   Other 13 (42) 89 (24) 39.8 13 (44) 13 (44) 0.1
  APACHE-II score† 3.3±2.9 7.7±4.2 124.8 3.7±2.9 3.1±2.8 10.0
  Cardiovascular failure, n (%)†‡ 0 7 (2) 19.5 0 0 0
  Pulmonary failure, n (%)†§ 0 30 (8) 42.4 0 0 0
  Renal failure, n (%)†¶ 0 10 (3) 23.4 0 0 0
  Documented infected necrosis, n (%)** 12 (39) 279 (74) 76.5 11 (38) 12 (41) 8.4
  Tertiary referral, n (%) 25 (81) 205 (55) 57.8 23 (79) 23 (79) 3.2
  Time since hospital admission, days 88±118 51±133 29.7 89±121 86±203 7.6
Endoscopic 
necrosectomy
(n=120)
Open 
necrosectomy
(n=343)
Standardised 
difference (%)
Endoscopic 
necrosectomy
(n=72)
Open 
necrosectomy
(n=72)
Standardised 
difference (%)
Intermediate risk of death (≥5% to <15%)
  Male sex, n (%) 85 (71) 229 (67) 9.2 49 (68) 48 (67) 2.4
  Age 50±14 53±14 2.1 53±14 54±13 3.6
  Cause,  (%)
   Gallstones 57 (48) 139 (40) 14.3 33 (46) 34 (47) 1.2
   Alcohol 29 (24) 119 (35) 23.4 20 (28) 21 (29) 3.1
   Other 34 (28) 85 (25) 8.0 19 (26) 17 (24) 4.7
  APACHE-II score† 6.5±3.1 10.0±4.1 96.7 7.4±2.8 7.4±3.6 0.5
  Cardiovascular failure, (%)†‡ 0 65 (19) 68.1 0 0 0
  Pulmonary failure, n (%)†§ 1 (1) 113 (33) 94.5 1 (1) 1 (1) 6.7
  Renal failure, n (%)†¶ 0 42 (12) 52.9 0 0 0
  Documented infected necrosis, n (%)** 59 (49) 270 (79) 64.3 46 (64) 47 (65) 3.1
  Tertiary referral, n (%) 80 (67) 208 (61) 12.8 46 (64) 45 (63) 1.0
  Time since hospital admission, days 48±51 30±27 42.9 36±30 37±29 2.9
Endoscopic 
necrosectomy
(n=133)
Open 
necrosectomy
(n=225)
Standardised 
difference (%)
Endoscopic 
necrosectomy
(n=40)
Open 
necrosectomy
(n=40)
Standardised 
difference (%)
High risk of death (≥15% to <35%)
  Male sex, n (%) 68 (51) 140 (62) 22.9 23 (58) 25 (63) 9.2
  Age 59±12 58±14 6.0 60±13 60±14 1.5
  Cause, n (%)
   Gallstones 66 (50) 88 (39) 21.5 16 (40) 18 (45) 5.1
   Alcohol 27 (20) 81 (36) 35.8 13 (32) 12 (30) 3.5
   Other 40 (30) 56 (25) 11.7 11 (28) 10 (25) 2.8
  APACHE-II score† 8.9±2.9 12.8±4.2 105.2 10.6±2.8 10.5±2.7 5.4
  Cardiovascular failure, n (%)†‡ 11 (8) 98 (44) 88.2 9 (23) 10 (25) 4.5
  Pulmonary failure, n (%)†§ 7 (5) 145 (65) 158.9 7 (18) 7 (18) 1.5
  Renal failure, n (%)†¶ 2 (2) 65 (29) 82.6 2 (5) 3 (8) 6.2
  Documented infected necrosis, n (%)** 76 (57) 182 (81) 53.3 32 (80) 32 (80) 2.7
  Tertiary referral, n (%) 96 (72) 160 (71) 2.1 29 (73) 31 (78) 9.3
  Time since hospital admission, days 59±84 24±19 57.7 27±15 27±20 3.5
Endoscopic 
necrosectomy
(n=62)
Open 
necrosectomy
(n=222)
Standardised 
difference (%)
Endoscopic 
necrosectomy
(n=57)
Open 
necrosectomy
(n=57)
Standardised 
difference (%)
Very high risk of death (≥35%)
  Male sex, n (%) 40 (65) 146 (66) 2.3 37 (65) 35 (61) 5.0
  Age 64±14 62±14 10.9 63±14 63±14 0.4
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Characteristics Before matching After matching
  Cause, n (%)
  Gallstones 37 (60) 99 (44) 30.6 34 (59) 33 (58) 0.6
  Alcohol 14 (22) 66 (30) 16.1 14 (25) 13 (23) 4.6
  Other 11 (18) 57 (26) 19.7 9 (16) 11 (19) 5.3
  APACHE-II score† 16.0±6.2 16.6±5.3 11.9 16.2±6.4 16.4±5.3 2.8
  Cardiovascular failure, n (%)†‡ 33 (53) 179 (81) 60.5 33 (58) 34 (60) 4.3
  Pulmonary failure, n (%)†§ 35 (56) 182 (82) 57.6 35 (61) 34 (60) 1.3
  Renal failure, n (%)†¶ 18 (29) 123 (55) 55.3 18 (32) 16 (28) 6.2
  Documented infected necrosis, n (%)** 50 (81) 154 (69) 26.8 46 (81) 46 (81) 0.2
  Tertiary referral, n (%) 48 (77) 168 (76) 3.8 45 (79) 43 (76) 6.7
  Time since hospital admission, days 36±24 22±18 65.0 33±17 33±22 2.9
*± Values are mean±SD. A value of less than 10.0% of the standardised difference indicates a negligible difference between groups. Patients are stratified in four risk groups 
based on predicted death at baseline, which was determined by a multivariable prediction model incorporating study cohort, APACHE-II score, cardiovascular failure, pulmonary 
failure and renal failure in the 24 hours before necrosectomy (details on prediction model in the online supplementary appendix p7).
†Within 24 hours before necrosectomy.
‡Circulatory systolic blood pressure <90 mm Hg, despite adequate fluid resuscitation or need for inotropic catecholamine support.
§PaO2 <60 mm Hg, despite FIO2 of 30% or need for mechanical ventilation.
¶Creatinine level >177 μmol/L after rehydration or need for haemofiltration or haemodialysis.
**Positive microbiological culture from fine-needle aspiration before necrosectomy or from first catheter drainage before necrosectomy or from primary necrosectomy.
Table 2 Continued 
Figure 1 Death rates in patients undergoing minimally invasive surgical necrosectomy and endoscopic necrosectomy as compared with patients 
undergoing open necrosectomy. Shown are actual death rates / total patients (%) for patients undergoing minimally invasive surgical necrosectomy 
(A) and endoscopic necrosectomy (B) as compared with patients undergoing open necrosectomy in the propensity-score matched cohorts. Patients 
are stratified in four risk groups based on predicted death at baseline (Low: <5%, Intermediate: ≥5% to <15%, High: ≥15% to <35% and Very high: 
≥35%) which was determined by a multivariable prediction model incorporating study cohort (ie, to adjust for hidden confounders), age, APACHE-II 
score, cardiovascular failure, pulmonary failure, and renal failure in the 24 hours before necrosectomy.
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are lower rates of pancreatic fistula as shown in our study 
and lower rates of long-term complications such as incisional 
hernias and endocrine or exocrine pancreatic insufficiency.15 17 
To fill the existing evidential gap on clinical outcome supe-
riority for the increasing popularity of minimally invasive 
necrosectomy, the primary aim of our study was to compare 
minimally invasive necrosectomy with open necrosectomy 
on the outcome in-hospital death. In our secondary analysis 
we compared endoscopic necrosectomy with minimally inva-
sive surgical necrosectomy. Although endoscopic treatment is 
considered the least invasive necrosectomy method, we did not 
find a statistically significant decrease in mortality. This could 
be explained by a type II error. Endoscopic techniques are 
rapidly developing, for example with the recent introduction 
of lumen apposing metal stents which show promising results 
with high clinical success rates.39 It is therefore expected that 
in the evolution of necrosectomy techniques, a shift will occur 
from open necrosectomy to minimally invasive necrosectomy 
to an increase in the use of endoscopic techniques.
Our study does not have the preferred design of a randomised 
trial. It is therefore possible that measurement errors and hidden 
or unknown confounding factors, which are not accounted for 
in our analyses, may have influenced results. Using per-protocol 
predefined case record forms for data extraction and well-defined 
patient inclusion criteria, however, reduced the risk of measure-
ment errors to a minimum. The included cohorts did not capture 
data on preoperative imaging, such as extent and location of 
peripancreatic necrosis on CT. These factors likely influenced 
the decisions to perform minimally invasive or open necrosec-
tomy in certain patients. For instance, small and centrally located 
peripancreatic collections are best accessible by endoscopy, 
whereas collections extending to the paracolic gutter may prefer 
a minimally invasive surgical approach. Notably, not all patients 
with necrotising pancreatitis are candidates for minimally inva-
sive techniques. A small minority of patients with extensive 
collections may only be suitable for an open surgical approach. 
Also, the time period in which necrosectomy was performed 
may have introduced unknown confounders (eg, supportive 
treatment on the intensive care unit may have improved over 
the years). As all three necrosectomy methods were performed 
in the most recent years (1998 and onward), overlap was judged 
to be sufficient for adjustment for year of necrosectomy in our 
first main (multivariable regression) analyses. This does not 
exclude all risks of lack of overlap in the regression analysis, 
however, because it may have led to extrapolation of the results 
from previous years to newer years. The insufficient overlap in 
the variable ‘year of necrosectomy’ between minimally invasive 
necrosectomy methods and open necrosectomy precluded the 
inclusion of year of necrosectomy as a factor in the propensity 
score matching. Too many patients from the control group (ie, 
open necrosectomy) would have been excluded, which would 
have led to a significant loss of matched pairs. We performed 
our study in the largest known cohort of patients undergoing 
necrosectomy for necrotising pancreatitis. In our analyses, we 
adjusted for important factors widely recognised as being associ-
ated with death. Unfortunately, the risk of residual confounding, 
which can only be eliminated by a randomised design, remains 
apparent. A randomised trial with a sample size large enough to 
detect a difference in mortality will, however, be very difficult to 
realise and no such trial is currently planned. Future randomised 
studies concentrating on patient-oriented outcomes such as 
health-related quality of life and hospital stay may serve as a 
valuable alternative. Until these are available, large observational 
studies, despite their inherent risk of persisting bias, yield the 
best available evidence to guide clinical decision making in this 
severe and complex disease. Because patients from 51 hospitals 
across 8 countries and 3 continents were included in this study, 
we believe our results are generalisable to patient populations 
with necrotising pancreatitis.
In conclusion, among severely ill patients with necrotising 
pancreatitis, minimally invasive surgical necrosectomy and 
endoscopic necrosectomy are associated with reduced death 
rates compared with open necrosectomy.
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